INDIGO Biosciences
Kelayres
About INDIGO Biosciences
INDIGO Biosciences supplements the receptor assay kits and services and in vitro toxicology solutions with greater readability, reproducibility, and faster turnaround times of the results. Their solutions, combined with a supportive team and reliable science and platforms, aim to reduce the time, cost, and risk associated with the discovery process.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $1.5M
- Funding stage: Early Stage Venture
- Last round: Series B (Feb 2018)
- Website: indigobiosciences.com
- Phone: +1 814 234 1919
Industries & Categories
Biotechnology, Medical Device, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/indigo-biosciences-140119 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.